Nioxin Pro Clinical Scalp Recovery Scalp Soothing Serum Lotion
NDC Package 82157-015-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Nioxin Pro Clinical Scalp Recovery Scalp Soothing Serum (pyrithione zinc) lotions is usesHelps prevent recurrence of flaking and itching associated with dandruff. This formulation utilizes a lotion delivery system. Marketed by The Wella Corporation, this product is identified by NDC 82157-015 and is authorized under FDA application M032.

Identification & Billing

NDC Package Code
82157-015-01
Package Description
100 mL in 1 BOTTLE, PLASTIC
Product Code
82157-015
11-Digit Billing Format
82157001501
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Nioxin Pro Clinical Scalp Recovery Scalp Soothing Serum
Non-Proprietary Name
Pyrithione Zinc
Substance Name
Pyrithione Zinc
Dosage Form
Lotion - An emulsion, liquid1 dosage form. This dosage form is generally for external application to the skin.2
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
PYRITHIONE ZINC .1 g/100mL
Usage Information
UsesHelps prevent recurrence of flaking and itching associated with dandruff.

Regulatory & Marketing

Labeler Name
The Wella Corporation
Product Type
Human Otc Drug
FDA Application #
M032
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
04-01-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (82157-015). Click a package code to view its specific billing and regulatory data.

82157-015-10
1 BOTTLE, PLASTIC in 1 CARTON / 100 mL in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 82157-015-01 identifies a specific commercial package of 100 ml in 1 bottle, plastic of Nioxin Pro Clinical Scalp Recovery Scalp Soothing Serum, a human over the counter drug labeled by The Wella Corporation. This lotion is formulated for topical use and contains pyrithione zinc as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by The Wella Corporation on April 01, 2025. The current certification is valid through December 31, 2026.

How is this The Wella Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 82157001501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
82157-015-01
11-Digit CMS (5-4-2)
82157-0015-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.